Innovative Solutions in Biotechnology
Transforming Tissue Banks & Bio Skills with artificial intelligence strategies.
Innovative Solutions in Biotechnology
Transforming Tissue Banks & Bio Skills with artificial intelligence strategies.
Transforming Tissue Banks & Bio Skills with artificial intelligence strategies.
Transforming Tissue Banks & Bio Skills with artificial intelligence strategies.
Marc Griesenbrock is a biotech serial entrepreneur with 30+ years of experience in key management positions in tissue bank operations and biotech research systems.
He started his career as a Surgical Tech specializing in tissue, ocular, and organ recovery and transplant. He co-founded LifeLegacy Foundation and CellzDirect. In 2003, he was instrumental in the acquisition of CEDRA Corp.
Marc has been a seed investor in numerous Biotech ventures, including CellzDirect (sold in 2008), Calimmune (sold in 2018), Innoved Institute (current), and Rampart Bioscience (current).
He is currently the Co-Founder and President of Sandlot Ventures, managing a wide array of investments in mining, oil & gas, real estate, and fintech.
Marc holds a B.S. in Molecular Cellular Biology from the University of Arizona. His ability to integrate his seed investment capital strategy with his biotech technology-driven efficiency solutions drives large-scale growth at many of the companies for which he has invested and held key executive leadership roles.
Michael J. Grammond is a tissue bank operations and research systems expert with 30+ years of experience.
Previously, he was the Regional Manager at Donor Network of Arizona and the co-founder and Director of Operations of Life Legacy Foundation (LLF) and International Bioresearch Solutions. He also served as the Executive Director and CEO of LLF.
Michael has been a seed investor in several Biotech ventures, including CellzDirect (sold in 2008), Calimmune (sold in 2018), and Innoved Institute (current).
He is currently the Chief Investment Officer for King Legacy Capital LLC. A next-generation AI wealth management firm that leverages financial engineering, neural networks, machine learning, and quantitative strategies to grow capital through providing an alternative to traditional banking with daily liquidity and maximized investment returns.
Michael holds a dual B.S. in Psychology and Biochemistry from the University of Arizona. He is also a board-certified CEBT (Certified Eye Bank Technician). His ability to integrate capital strategy with biotech seed investments and technology-driven efficiency solutions drives large-scale growth at the company, for which he holds executive leadership roles.
Sofia Lyon is a serial entrepreneur, political strategist, and financial innovator with a track record of building high-performance organizations across finance, technology, law, and national politics. She is the Founder & CEO of King Legacy Capital LLC. A next-generation AI wealth management firm that leverages financial engineering, neural networks, machine learning, and quantitative strategies to grow capital through providing an alternative to traditional banking with daily liquidity and maximized investment returns.
She is also the Founder & CEO of Lyon Premier Strategies LLC, a national fundraising firm serving U.S. Congress and U.S. Senate campaigns, Super PACs, PACs, and leading nonprofit and for-profit organizations.
Previously, Sofia served as Chief Operating Officer of Trailmapper, Inc., a high-impact fundraising technology platform for political and advocacy organizations. Her earlier career includes serving as Finance Director for competitive Gubernatorial campaigns and holding senior finance and strategy roles in multiple U.S. Senate campaigns.
Sofia holds a dual B.A. in Political Science and Law from the University of Arizona and is pursuing an executive LLM in International Financial Law at King's College London. Her ability to integrate capital strategy, creative financing, high-net-worth relationship management, and technology-driven solutions drives large-scale growth at the companies for which she serves as an executive.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.